Company Name: Sunesis Pharmaceuticals, Inc.

Sunesis Pharmaceuticals, Inc. is a biopharmaceutical company. The company is engaged in the development of oncology therapeutics for solid and hematologic cancers. The company’s lead product candidate is a potential treatment for acute myeloid leukemia (AML).

Ticker Symbol: SNSS (NASDAQ)

Company Website: www.sunesis.com

Social Media: Sunesis Pharmaceuticals LinkedIn

Headquarters: South San Francisco, CA